StonvexLoading…
StonvexStonvexStonvexCore line items from CSTE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $397.23M | $443.22M | $565.23M | $690.81M |
Operating Income | $-125.71M | $-41.89M | $-88.03M | $-58.69M |
Net Income | $-137.47M | $-42.83M | $-107.66M | $-57.05M |
EPS (Diluted) | $-3.98 | $-1.13 | $-3.13 | $-1.66 |
Total Assets | $398.44M | $549.04M | $579.86M | $752.98M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $58.44M | $57.34M | $54.62M | $52.08M |
Free Cash Flow OCF − CapEx | $-47.06M | $21.45M | $55.36M | $-41.11M |
Shares Outstanding | 34.57M | 34.55M | 34.53M | 34.51M |